Sigma-Aldrich Sees 7-Percent Q3 Revenue Growth as Profits Rise 7 Percent | GenomeWeb
The net income that originally appeared in this article reported earnings for the 9-month period ended Sept. 30 and showed a 2-percent increase year over year. The story has been corrected to reflect profit for the three months ended Sept. 30, which reflect a 7-percent increase.
 
NEW YORK (GenomeWeb News) — Sigma-Aldrich today said that third-quarter revenue increased 7 percent as R&D spending grew and profit inched up 7 percent.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.